Nogi, Japan

Michiro Ohnota

This inventor holds 5 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1993-2004.


% Patents Active = 60.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Nogi, JP (1993 - 1994)
  • Nagano, JP (2004)

Company Filing History:


Years Active: 1993-2004

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michiro Ohnota: Innovator in Pharmaceutical Chemistry

Introduction

Michiro Ohnota is a prominent inventor based in Nogi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 5 patents to his name, Ohnota's work has had a substantial impact on drug formulation and production.

Latest Patents

Ohnota's latest patents include innovative methods and compounds that enhance the stability and production efficiency of pharmaceutical products. One of his notable inventions is the alkali metal salt of thiazolidine-2,4-dione derivative. This invention provides an alkali metal salt of 5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide and its hydrate. The method discovered allows for the industrial purification of KRP-297, making it advantageous for large-scale production. Another significant patent is for a stable crystal of thiazolidinedione derivative and the process for producing the same. This homogeneous crystal exhibits excellent stability and is suitable for the industrial-scale production of KRP-297, characterized by specific diffraction angles in X-ray powder diffractometry.

Career Highlights

Ohnota is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the production processes of complex pharmaceutical compounds, ensuring their stability and efficacy.

Collaborations

Throughout his career, Ohnota has collaborated with esteemed colleagues such as Yoshihiro Hirata and Koji Murakami. These collaborations have fostered a productive environment for research and development, leading to groundbreaking advancements in their field.

Conclusion

Michiro Ohnota's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work not only enhances drug production but also paves the way for future advancements in pharmaceutical formulations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…